{"id":788,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"sermorelin-ghrh-1-29-amide-identity-lcms-guide","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/","title":{"rendered":"Guia de identidade Sermorelin: GHRH (1 \u2013 29) -Amida e LC-MS"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Sermorelin \u00e9 um pept\u00eddeo de res\u00edduo 29 amidado correspondente \u00e0 regi\u00e3o N-terminal ativa do GHRH humano. A amida C-terminal define a identidade.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Evid\u00eancias em resumo<\/h2><ul class=\"wp-block-list\"><li>PubChem lista a f\u00f3rmula C149H246N44O42S e o peso molecular 3357.9 g\/mol para Sermorelin.<\/li><li>A sequ\u00eancia \u00e9 YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2.<\/li><li>Um m\u00e9todo LC-HRMS\/MS de plasma validado relatou limites inferiores de detec\u00e7\u00e3o abaixo de 50 pg\/mL com recupera\u00e7\u00e3o de 19\u201337% e imprecis\u00e3o abaixo de 20%.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp\" alt=\"Cena documental da instala\u00e7\u00e3o central LC-MS\" class=\"wp-image-772\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality-300x169.webp 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality-1024x576.webp 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality-768x432.webp 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality-1536x864.webp 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">Ilustra\u00e7\u00e3o editorial gerada por AI ilustrando um fluxo de trabalho anal\u00edtico. N\u00e3o representa produto fornecido, lote liberado, formula\u00e7\u00e3o aprovada ou resultado de ensaio.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Registro de identidade<\/h2><p class=\"wp-block-paragraph\">O acetato Sermorelin e Sermorelin de base livre precisa de contabilidade separada de massa e conte\u00fado. O r\u00f3tulo deve deixar claro se a quantidade do cat\u00e1logo se refere ao material total ou ao equivalente pept\u00eddico.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Comprimento<\/strong><span>Amino\u00e1cidos 29<\/span><\/div><div class=\"pim-evidence-row\"><strong>Formul\u00e1rio terminal<\/strong><span>Amida C-terminal<\/span><\/div><div class=\"pim-evidence-row\"><strong>F\u00f3rmula e massa<\/strong><span>C149H246N44O42S; 3357.9g\/mol<\/span><\/div><div class=\"pim-evidence-row\"><strong>PubChem<\/strong><span>CID 16132413<\/span><\/div><div class=\"pim-evidence-row\"><strong>M\u00e9todo de plasma humano<\/strong><span>Purifica\u00e7\u00e3o por imunoafinidade mais nano-UHPLC-HRMS\/MS<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Limite anal\u00edtico e de evid\u00eancia<\/h2><p class=\"wp-block-paragraph\">O estudo de detec\u00e7\u00e3o de 2016 demonstrou recupera\u00e7\u00e3o anal\u00edtica de plasma humano fortificado para Sermorelin e an\u00e1logos relacionados de GHRH. Foi um estudo de valida\u00e7\u00e3o de m\u00e9todo antidoping, n\u00e3o um estudo de efic\u00e1cia terap\u00eautica.<\/p><p class=\"wp-block-paragraph\">Um registro de lote completo deve combinar sequ\u00eancia ou massa intacta de alta resolu\u00e7\u00e3o, cromatografia, base de conte\u00fado, informa\u00e7\u00f5es de \u00e1gua e contra-\u00edons. Um limite de detec\u00e7\u00e3o de plasma n\u00e3o substitui as especifica\u00e7\u00f5es de libera\u00e7\u00e3o do produto.<\/p><h2 class=\"wp-block-heading\">Regra editorial<\/h2><p class=\"wp-block-paragraph\">Indique o material, forma, modelo ou popula\u00e7\u00e3o exatos e o ponto final suportado pelo registro citado. N\u00e3o converta a plausibilidade mecanicista, um resultado animal, um r\u00f3tulo oficial de medicamento acabado ou um teste anal\u00edtico em uma afirma\u00e7\u00e3o sobre um lote de cat\u00e1logo n\u00e3o relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>Sermorelin \u00e9 um pept\u00eddeo de res\u00edduo 29 amidado correspondente \u00e0 regi\u00e3o N-terminal ativa do GHRH humano. A amida C-terminal define a identidade.<\/p>","protected":false},"author":1,"featured_media":772,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"362","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"PubChem sequence identity plus validated human-plasma detection literature","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"GRF1-29 stimulation in normal subjects\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/6240568\/\",\"note\":\"Primary human physiology study; PMID 6240568.\"},{\"title\":\"Low-dose GHRH(1\u201329)-amide dose-response study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7921207\/\",\"note\":\"Primary human dose-response study; PMID 7921207.\"},{\"title\":\"Sermorelin pediatric review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18031173\/\",\"note\":\"Historical diagnostic and pediatric treatment review; PMID 18031173.\"},{\"title\":\"GHRH analog detection in human plasma\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26879649\/\",\"note\":\"Validated LC-HRMS\/MS method; PMID 26879649.\"},{\"title\":\"PubChem Sermorelin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sermorelin\",\"note\":\"Sequence, formula and molecular weight; CID 16132413.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS<\/title>\n<meta name=\"description\" content=\"Sermorelin is an amidated 29-residue peptide corresponding to the active N-terminal region of human GHRH. The C-terminal amide is identity-defining.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS\" \/>\n<meta property=\"og:description\" content=\"Sermorelin is an amidated 29-residue peptide corresponding to the active N-terminal region of human GHRH. The C-terminal amide is identity-defining.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-quality.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/\",\"name\":\"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-quality.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Sermorelin is an amidated 29-residue peptide corresponding to the active N-terminal region of human GHRH. The C-terminal amide is identity-defining.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-quality.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/sermorelin-quality.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: LC-MS core facility scene\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guia de identidade Sermorelin: GHRH (1 \u2013 29) -Amida e LC-MS","description":"Sermorelin \u00e9 um pept\u00eddeo de res\u00edduo 29 amidado correspondente \u00e0 regi\u00e3o N-terminal ativa do GHRH humano. A amida C-terminal define a identidade.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/","og_locale":"pt_BR","og_type":"article","og_title":"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS","og_description":"Sermorelin is an amidated 29-residue peptide corresponding to the active N-terminal region of human GHRH. The C-terminal amide is identity-defining.","og_url":"https:\/\/nhdbio.com\/pt-br\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/","url":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/","name":"Guia de identidade Sermorelin: GHRH (1 \u2013 29) -Amida e LC-MS","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Sermorelin \u00e9 um pept\u00eddeo de res\u00edduo 29 amidado correspondente \u00e0 regi\u00e3o N-terminal ativa do GHRH humano. A amida C-terminal define a identidade.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/sermorelin-quality.webp","width":1672,"height":941,"caption":"AI-generated illustration: LC-MS core facility scene"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/sermorelin-ghrh-1-29-amide-identity-lcms-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Sermorelin Identity Guide: GHRH(1\u201329)-Amide and LC-MS"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe T\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=788"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/788\/revisions"}],"predecessor-version":[{"id":1199,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/788\/revisions\/1199"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/772"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}